Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice

Human Gene Therapy

Volumn 11, Issue 5, 2000, Pages 669-680

  Yamamoto, Kanji ^a,b   Yuasa, Katsutoshi ^a   Miyagoe, Yuko ^a   Hosaka, Yukio ^a   Tsukita, Kayoko ^a   Yamamoto, Hiroshi ^c   Nabeshima, Yo Ichi ^a,d   Takeda, Shin'ichi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD4 ANTIGEN; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; TACROLIMUS; UTROPHIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE REGENERATION; NONHUMAN; SARCOLEMMA;

ADENOVIRIDAE; ANIMALS; ANTIGENS; ANTIGENS, CD4; BETA-GALACTOSIDASE; CYTOSKELETAL PROTEINS; DIRECT LYTIC FACTORS; DYSTROPHIN; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IMMUNOSUPPRESSION; LUMINESCENT PROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; REGENERATION; SARCOLEMMA; TACROLIMUS; UP-REGULATION; UTROPHIN;

ADENOVIRIDAE; ANIMALIA;

EID: 0034689474     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015572     Document Type: Article

References (52)

1. Acsadi, G., Lochmüller, H., Jani, A., Huard, J., Massie, B., Prescott, S., Simoneau, M., Petrof, B.J., and Karpati, G. (1996). Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7, 129-140.
2. Benjamin, R.J., and Waldmann, H. (1986). Induction of tolerance by monoclonal antibody therapy. Nature (London) 320, 449-451.
3. Chen, H.-H., Mack, L.M., Choi, S.-Y., Ontell, M., Kochanek, S., and Clemens, P.R. (1999). DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle. Hum. Gene Ther. 10, 365-373.
4. Deconinck, A.E., Rafael, J.A., Skinner, J.A., Brown, S.C., Potter, A.C., Metzinger, L., Watt, D.J., Dickson, G., Tinsley, J.M., and Davies, K.E. (1997). Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90, 717-727.
5. Deconinck, N., Tinsley, J., De Backer, F., Fisher, R., Kahn, D., Phelps, S., Davies, K., and Gillis, J.-M. (1997). Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Med. 3, 1216-1221.
6. Emery, A.E.H. (1993). Duchenne Muscular Dystrophy, 2nd Ed. (Oxford University Press, Oxford).
7. Grady, R.M., Teng, H., Nichol, M.C., Cunningham, J.C., Wilkinson, R.S., and Sanes, J.R. (1997). Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: A model for Duchenne muscular dystrophy. Cell 90, 729-738.
8. Gramolini, A.O., Burton, E.A., Tinsley, J.M., Ferns, M.J., Cartaud, A., Cartaud, J., Davies, K.E., Lunde, J.A., and Jasmin, B.J. (1998). Muscle and neural isoforms of agrin increase utrophin expression in cultured myotubes via a transcriptional regulatory mechanism. J. Biol. Chem. 273, 736-743.
9. Gramolini, A.O., Angus, L.M., Schaeffer, L., Burton, E.A., Tinsley, J.M., Davies, K.E., Changeux, J.P., and Jasmin, B.J. (1999). Induction of utrophin gene expression by heregulin in skeletal muscle cells: Role of the N-box motif and GA binding protein. Proc. Natl. Acad. Sci. U.S.A. 96, 3223-3227.
10. Gullberg, D., Velling, T., Sjöberg, G., Salmivirta, K., Gaggero, B., Tiger, C.-F., Edström, L., and Sejersen, T. (1997). Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis. Neuromusc. Disord. 7, 39-54.
11. Gussoni, E., Blau, H.M., and Kunkel, L.M. (1997). The fate of individual myoblasts after transplantation into muscles of DMD patients. Nature Med. 3, 970-977.
12. Hayashi, Y.K., Chou, F.-L., Engvall, E., Ogawa, M., Matsuda, C., Hirabayashi, S., Yokochi, K., Ziober, B.L., Kramer, R.H., Kaufman, S.J., Ozawa, E., Goto, Y., Nonaka, I., Tsukahara, T., Wang, J., Hoffman, E.P., and Arahata, K. (1998). Mutations in the integrin α7 gene cause congenital myopathy. Nature Genet. 19, 94-97.
13. Helliwell, T.R., Nguyen Thim., Morris, G.E., and Davies, K.E. (1992). The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromusc. Disord. 2, 177-184.
14. Imamura, M., and Ozawa, E. (1998). Differential expression of dystrophin isoforms and utrophin during dibutyryl-cAMP-induced morphological differentiation of rat brain astrocytes. Proc. Natl. Acad. Sci. U.S.A. 95, 6139-6144.
15. Ishii, A., Hagiwara, Y., Saito, Y., Yamamoto, K., Yuasa, K., Sato, Y., Arahata, K., Shoji, S., Nonaka, I., Saito, I., Nabeshima, Y., and Takeda, S. (1999). Effective adenovirus-mediated gene expression in adult murine skeletal muscle. Muscle Nerve 22, 592-599.
16. Iwata, H., Kitagawa, S., Sato, S., Kosugi, A., Hirose, H., Hamaoka, T., Shearer, G.M., and Fujiwara, H. (1993). Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. Transplantation 56, 173-180.
17. Jooss, K., Yang, Y., Fisher, K.J., and Wilson, J.M. (1998). Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72, 4212-4223.
18. Kafri, T., Morgan, D., Krahl, T., Sarvetnick, N., Sherman, L., and Verma, I. (1998). Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 95, 11377-11382.
19. Kameya, S., Miyagoe, Y., Nonaka, I., Ikemoto, T., Endo, M., Hanaoka, K., Nabeshima, Y., and Takeda, S. (1999). α1-Syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J. Biol. Chem. 274, 2193-2200.
20. Kanegae, Y., Makimura, M., and Saito, I. (1994). A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47, 157-166.
21. Karpati, G., Carpenter, S., Morris, G.E., Davies, K.E., Guerin, C., and Holland, P. (1993). Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropathol. Exp. Neurol. 52, 119-128.
22. Khurana, T.S., Watkins, S.C., Chafey, P., Chelly, J., Tomé, F.M.S., Fardeau, M., Kaplan, J.-C., and Kunkel, L.M. (1991). Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromusc. Disord. 1, 185-194.
23. Khurana, T.S., Rosmarin, A.G., Shang, J., Krag, T.O.B., Das, S., and Gammeltoft, S. (1999). Activation of utrophin promoter by heregulin via the est-related transcription factor complex GA-binding protein α/β. Mol. Biol. Cell 10, 2075-2086.
24. Kochanek, S., Clemens, P.R., Mitani, K., Chen, H.-H., Chan, S., and Caskey, T. (1996). A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. U.S.A. 93, 5731-5736.
25. Li, J.-J., Ueno, H., Tomita, H., Yamamoto, H., Kanegae, Y., Saito, I., and Takeshita, A. (1995). Adenovirus-mediated arterial gene transfer does not require prior injury for submaximal gene expression. Gene Ther. 2, 351-354.
26. Love, D.R., Morris, G.E., Ellis, J.M., Fairbrother, U., Marsden, R.F., Bloomfield, J.F., Edwards, Y.H., Slater, C.P., Parry, D.J., and Davies, K.E. (1991). Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. Proc. Natl. Acad. Sci. U.S.A. 88, 3243-3247.
27. Matsuda, R., Nishikawa, A., and Tanaka, H. (1995). Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: Evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. 118, 959-964.
28. Matsumura, K., Ervasti, J.M., Ohlendieck, K., Kahl, S.D., and Campbell, K.P. (1992). Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature (London) 360, 588-591.
29. Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., and Saito, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U.S.A. 93, 1320-1324.
30. Nagaraju, K., Raben, N., Merritt, G., Loeffler, L., Kirk, K., and Plotz, P. (1998). A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin. Exp. Immunol. 113, 407-414.
31. Niwa, H., Yamamura, K., and Miyazaki, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-200.
32. Ohlendieck, K., Ervasti, J.M., Matsumura, K., Kahl, S.D., Leveille, C.J., and Campbell, K.P. (1991). Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7, 499-508.
33. Pearce, M., Blake, D.J., Tinsley, J.M., Byth, B.C., Campbell, L., Monaco, A.P., and Davies, K.E.(1993). The utrophin and dystrophin genes share similarities in genomic structure. Hum. Mol. Genet. 2, 1765-1772.
34. Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Couton, D., Cartaud, J., Briand, P., Kaplan, J.-C., Perricaudet, M., and Kahn, A. (1993). Efficeint adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (London) 361, 647-650.
35. Schiaffino, S., Gorza, L., Pitton, G., Saggin, L., Ausoni, S., Sartore, S., and Lomo, T. (1988). Embryonic and neonatal myosin heavy chain in denervated and paralyzed rat skeletal muscle. Dev. Biol. 127, 1-11.
36. Settles, D.L., Cihak, R.A., and Erickson, H.P. (1996). Tenascin-C expression in dystrophin-related muscular dystrophy. Muscle Nerve 19, 147-154.
37. Sigal, L.J., Crotty, S., Andino, R., and Rock, K.L. (1999). Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature (London) 398, 77-80.
38. Straub, V., Rafael, J.A., Chamberlain, J.S. and Campbell, K.P. (1997). Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375-385.
39. Talts, J.F., Eng, H., Zhang, H.-Y., Faissner, A., and Ekblom, P. (1997). Characterization of monoclonal antibodies against tenascin-C: No apparent effect on kidney development in vitro. Int. J. Dev. Biol. 41, 39-48.
40. Tanaka, H., Ishiguro, T., Eguchi, C., Saito, K., and Ozawa, E. (1991). Expression of a dystrophin-related protein associated with the skeletal muscle cell membrane. Histochemistry 96, 1-5.
41. Teijeira, S., Teijeiro, A., Fernandez, R., and Navarro, C. (1998). Subsarcolemmal expression of utrophin in neuromuscular disorders: An immunohistochemical study of 80 cases. Acta Neuropathol. 96, 481-486.
42. Tinsley, J.M., Blake, D.J., Roche, A., Fairbrother, U., Riss, J., Byth, B.C., Knight, A.E., Kendrick-Jones, J., Suthers, G.K., Love, D.R., Edwards, Y.H., and Davies, K.E. (1992). Primary structure of dystrophin-related protein. Nature (London) 360, 591-593.
43. Tinsley, J.M., Potter, A.C., Phelps, S.R., Fisher, R., Trickett, J.I., and Davies, K.E. (1996). Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature (London) 384, 349-353.
44. Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J.-M., and Davies, K. (1998). Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nature Med. 4, 1441-1444.
45. Tisdale, M.J. (1997). Biology of cachexia. J. Natl. Cancer Inst. 89, 1763-1773.
46. Tripathy, S.K., Black, H.B., Goldwasser, E., and Leiden, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550.
47. Turner, G., Dunckley, M.G., and Dickson, G. (1997). Gene therapy of Duchenne muscular dystrophy. In Dystrophin: Gene, Protein and Cell Biology. S.C. Brown and J.A. Lucy, eds. (Cambridge University Press, Cambridge) pp. 274-309.
48. Vater, R., Cullen, M.J., and Harris, J.B. (1994). The expression of vimentin in satellite cells of regenerating skeletal muscle in vivo. Histochem. J. 26, 916-928.
49. Wakayama, Y., Inoue, M., Murahashi, M., Shibuya, S., Jimi, T., Kojima, H., and Oniki, H. (1996). Ultrastructural localization of adhalin in normal murine skeletal myofiber. Ann. Neurol. 39, 217-223.
50. Wells, D.J., Wells, K.E., Asante, E.A., Turner, G., Sunada, Y., Campbell, K.P., Walsh, F.S., and Dickson, G. (1995). Expression of human full-length and minidystrophin in transgenic mdx mice: Implications for gene therapy of Duchenne muscular dystrophy. Hum. Mol. Genet. 4, 1245-1250.
51. Yang, Y., Haecker, S.E., Su, Q., and Wilson, J.M. (1996). Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5, 1703-1712.
52. Yuasa, K., Miyagoe, Y., Yamamoto, K., Nabeshima, Y., Dickson, G., and Takeda, S. (1998). Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs. FEBS Lett. 425, 329-336.